Replies to post #16036 on Momenta Pharmaceuticals, Inc. (MNTA)

[biotech_researcher]

"AMGN not launching Amjevita—(Humira FoB)—until 2018 or later"

Dew, I can read this either way (positive/negative) as it relates to MNTA. What would be your take on this?-thanks.